Home > Publications Database > Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease > Access to Fulltext |
![]() |
|||||||
version 1 |
|
Restricted | |||||||
![]() |
|||||||
version 1 |
|
Restricted | |||||||
![]() |
|||||||
version 1 |
|
Restricted | |||||||
![]() |
|||||||
version 1 |
|